» Articles » PMID: 18218782

Cytoplasmic Pink1 Activity Protects Neurons from Dopaminergic Neurotoxin MPTP

Overview
Specialty Science
Date 2008 Jan 26
PMID 18218782
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

PTEN-induced putative kinase 1 (Pink1) is a recently identified gene linked to a recessive form of familial Parkinson's disease (PD). The kinase contains a mitochondrial localization sequence and is reported to reside, at least in part, in mitochondria. However, neither the manner by which the loss of Pink1 contributes to dopamine neuron loss nor its impact on mitochondrial function and relevance to death is clear. Here, we report that depletion of Pink1 by RNAi increased neuronal toxicity induced by MPP(+). Moreover, wild-type Pink1, but not the G309D mutant linked to familial PD or an engineered kinase-dead mutant K219M, protects neurons against MPTP both in vitro and in vivo. Intriguingly, a mutant that contains a deletion of the putative mitochondrial-targeting motif was targeted to the cytoplasm but still provided protection against 1-methyl-4-phenylpyridine (MPP(+))/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced toxicity. In addition, we also show that endogenous Pink1 is localized to cytosolic as well as mitochondrial fractions. Thus, our findings indicate that Pink1 plays a functional role in the survival of neurons and that cytoplasmic targets, in addition to its other actions in the mitochondria, may be important for this protective effect.

Citing Articles

A long-lived pool of PINK1 imparts a molecular memory of depolarization-induced activity.

Pollock L, Georgiou I, Rusilowicz-Jones E, Clague M, Urbe S Sci Adv. 2025; 11(9):eadr1938.

PMID: 40020067 PMC: 11870087. DOI: 10.1126/sciadv.adr1938.


Toxic interactions between dopamine, α-synuclein, monoamine oxidase, and genes in mitochondria of Parkinson's disease.

Naoi M, Maruyama W, Shamoto-Nagai M, Riederer P J Neural Transm (Vienna). 2024; 131(6):639-661.

PMID: 38196001 DOI: 10.1007/s00702-023-02730-6.


Mitochondrial dysfunction in Parkinson's disease - a key disease hallmark with therapeutic potential.

Henrich M, Oertel W, Surmeier D, Geibl F Mol Neurodegener. 2023; 18(1):83.

PMID: 37951933 PMC: 10640762. DOI: 10.1186/s13024-023-00676-7.


Calcineurin inhibition protects against dopamine toxicity and attenuates behavioral decline in a Parkinson's disease model.

Mondal R, Banerjee C, Nandy S, Roy M, Chakraborty J Cell Biosci. 2023; 13(1):140.

PMID: 37528492 PMC: 10394860. DOI: 10.1186/s13578-023-01068-6.


PINK1-PRKN mediated mitophagy: differences between and models.

Han R, Liu Y, Li S, Li X, Yang W Autophagy. 2022; 19(5):1396-1405.

PMID: 36282767 PMC: 10240983. DOI: 10.1080/15548627.2022.2139080.


References
1.
Unoki M, Nakamura Y . Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Oncogene. 2001; 20(33):4457-65. DOI: 10.1038/sj.onc.1204608. View

2.
Dodson M, Guo M . Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol. 2007; 17(3):331-7. DOI: 10.1016/j.conb.2007.04.010. View

3.
Zhang L, Shimoji M, Thomas B, Moore D, Yu S, Marupudi N . Mitochondrial localization of the Parkinson's disease related protein DJ-1: implications for pathogenesis. Hum Mol Genet. 2005; 14(14):2063-73. DOI: 10.1093/hmg/ddi211. View

4.
Deng H, Jankovic J, Guo Y, Xie W, Le W . Small interfering RNA targeting the PINK1 induces apoptosis in dopaminergic cells SH-SY5Y. Biochem Biophys Res Commun. 2005; 337(4):1133-8. DOI: 10.1016/j.bbrc.2005.09.178. View

5.
Greene J, Whitworth A, Kuo I, Andrews L, Feany M, Pallanck L . Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc Natl Acad Sci U S A. 2003; 100(7):4078-83. PMC: 153051. DOI: 10.1073/pnas.0737556100. View